Series A · Healthtech · Barcelona, Spain · Founded 2024 · 79–250 employees
Biorce is a Barcelona-based HealthTech company developing Aika, a native AI platform that streamlines the design and execution of clinical trials for pharmaceutical companies, biotech firms, and CROs. Its platform is trained on a proprietary database of over 1 million past clinical trials and supports protocol design, feasibility assessment, site selection, and regulatory preparation — reducing clinical trial preparation timelines and protocol amendments by up to 50%. Founded in 2024 by Pedro Coelho, Clara Bernardes, José Faria, and Diogo Pisoeiro, Biorce has raised over $62M in total funding, including a $52.5M Series A in February 2026 led by DST Global Partners — reportedly the largest Series A in Iberian healthtech and AI. The company ended 2025 approximately 200% above its revenue target and is expanding aggressively into the US market with a new R&D centre in Austin, Texas.
No open roles listed right now.